Şunu aradınız:: choriogonadotropin (Maltaca - İngilizce)

choriogonadotropin alfa.
choriogonadotropin alfa

choriogonadotropin alfa 250 mikrogrammi (6500 iu).
choriogonadotropin alfa 250 micrograms (6500 iu).

choriogonadotropin alfa użu għal taħt il- ġilda.
ovitrelle 250 micrograms/ 0.5 ml solution for injection in a pre-filled syringe choriogonadotropin alfa subcutaneous use.

250 mikrogrammi (6500 iu) ta ’ choriogonadotropin alfa.
250 micrograms (6500 iu) of choriogonadotropin alfa

choriogonadotropin alfa * 250 mikrogrammi f’ 0. 5 millilitru.
choriogonadotropin alfa* 250 micrograms in 0.5 ml.

is- sustanza attiva hija choriogonadotropin alfa, kull fjala fiha 285 mikrogrammi.
the active substance is choriogonadotropin alfa, each vial contains 285 micrograms.

ovitrelle 250 mikrograami trab u solvent għal soluzzjoni għall- injezzjoni choriogonadotropin alfa.
choriogonadotropin alfa.

is-sustanza attiva hi choriogonadotropin alfa prodotta minn teknoloġija ta’ dna rikombinanti.
the active substance is choriogonadotropin alfa, produced by recombinant dna technology.

ma teżisti l-ebda data dwar il-ħruġ ta’ choriogonadotropin alfa fil-ħalib.
there are no data on the excretion of choriogonadotropin alfa in milk.

biex ikun assigurat li doża tkun ta ’ 250 mikrogrammi, kull fjala fiha 285 mikrogrammi ta ’ choriogonadotropin alfa.
to ensure delivery of a 250 microgram dose, each vial contains 285 micrograms of choriogonadotropin alfa.

m’hemmx indikazzjoniet li choriogonadotropin alfa jiġi metaboliżżat u maħruġ b’mod differenti mill-hcg endoġeniku.
there are no indications that choriogonadotropin alfa is metabolised and excreted differently than endogenous hcg.

kull pinna mimlija għal-lest fiha 250 mikrogrammi (madwar 6,500 iu) ta’ choriogonadotropin alfa.
each prefilled pen contains 250 micrograms (approximately 6,500 iu) choriogonadotropin alfa

ma saru l-ebda studji dwar ir-riproduzzjoni permezz choriogonadotropin alfa fuq annimali (ara sezzjoni 5.3).
no reproduction studies with choriogonadotropin alfa in animals were performed (see section 5.3).

ovitrelle fih mediċina msejħa ‘choriogonadotropin alfa’, li ssir f’laboratorju minn teknika speċjali ta’ dna rikombinanti.
ovitrelle contains a medicine called ‘choriogonadotropin alfa’, made in a laboratory by a special recombinant dna technique.

jekk inti allerġika għal choriogonadotropin alfa jew għal xi sustanza oħra ta’ din il-mediċina (elenkati fis-sezzjoni 6).
if you are allergic to choriogonadotropin alfa or any of the other ingredients of this medicine ( listed in section 6).

kull fjala ta ’ trab fiha 285 mikrogrammi ta ’ choriogonadotropin alfa u kull kontenitur ta ’ solvent fiha 1 miliimetru ta ’ ilma għall- injezzjoni.
each vial of powder contains 285 micrograms of choriogonadotropin alfa and each container of solvent contains 1 ml of water for injections.

choriogonadotropin alfa hu prodott permezz ta ’ teknoloġija ta ’ dna rikombinat f’ ċelloli ta ’ l- ovarji tal- ħamster Ċiniż.
choriogonadotropin alfa is produced by recombinant dna technology in chinese hamster ovary cells.

wara teħid minn taħt il- ġilda, choriogonadotropin alfa jitneħħa mill- ġisem b’ nofs ħajja terminali ta ’ madwar 30 siegħa, u l- biodisponibilita assoluta hi ta ’ madwar 40%.
5 following subcutaneous administration, choriogonadotropin alfa is eliminated from the body with a terminal half-life of about 30 hours, and the absolute bioavailability is about 40%.